Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  EGFR inhibitor ABT-414
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
A Study of ABT-414 in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 99
Trial IDs: M13-813, NCI-2015-01852, 2015-001166-26, NCT02573324
Start Over